Bruker (BRKR) EPS (Weighted Average and Diluted) (2016 - 2025)
Bruker (BRKR) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with $0.1 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 11.11% year-over-year to $0.1, compared with a TTM value of -$0.15 through Dec 2025, down 119.74%, and an annual FY2025 reading of -$0.15, down 119.74% over the prior year.
- EPS (Weighted Average and Diluted) was $0.1 for Q4 2025 at Bruker, up from -$0.41 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $1.4 in Q4 2023 and bottomed at -$0.41 in Q3 2025.
- Average EPS (Weighted Average and Diluted) over 5 years is $0.37, with a median of $0.38 recorded in 2021.
- The sharpest move saw EPS (Weighted Average and Diluted) surged 428.57% in 2021, then tumbled 251.85% in 2025.
- Year by year, EPS (Weighted Average and Diluted) stood at $0.49 in 2021, then skyrocketed by 34.69% to $0.66 in 2022, then skyrocketed by 112.12% to $1.4 in 2023, then plummeted by 93.57% to $0.09 in 2024, then grew by 11.11% to $0.1 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for BRKR at $0.1 in Q4 2025, -$0.41 in Q3 2025, and $0.05 in Q2 2025.